Karl Erik Clausen
Pharmaceutical Sciences
Unilabs
Switzerland
Biography
He joined Unilabs in September 2017 as Interim Chief Financial Officer. From October 2014 to May 2017, he was CFO at Unilabs until he retired to pursue a private venture. Prior to joining Unilabs, Mr. Clausen held the role of CFO & COO at Bio Products Laboratory, a pharmaceutical company in the plasma industry based in the UK. Before that, Mr. Clausen was CFO and Member of the Management Board of Octopharma Group for approximately 9 years. Since 1995, Karl Erik has held the CFO position in different international companies. Between 1992 and 1995, he worked as International Group Controller in joint ventures with Roulands Fabriker A/S. He also worked for 6 years with Deloitte & Touche, where he was leading audit teams for medium-sized companies.
Research Interest
Pharmaceutical Sciences